A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma

10.1038/s41408-022-00768-5

Saved in:

Bibliographic Details
Main Authors:	Chng, WJ, Lonial, S, Morgan, GJ, Iida, S, Moreau, P, Kumar, SK, Twumasi-Ankrah, P, Villarreal, M, Dash, AB, Vorog, A, Zhang, X, Suryanarayan, K, Labotka, R, Dimopoulos, MA, Rajkumar, SV
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	Springer Science and Business Media LLC 2023
Subjects:	Humans Multiple Myeloma Lenalidomide Dexamethasone Boron Compounds Chromosome Aberrations Antineoplastic Combined Chemotherapy Protocols
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/237477
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-237477
record_format	dspace
spelling	sg-nus-scholar.10635-2374772023-08-30T22:13:13Z A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma Chng, WJ Lonial, S Morgan, GJ Iida, S Moreau, P Kumar, SK Twumasi-Ankrah, P Villarreal, M Dash, AB Vorog, A Zhang, X Suryanarayan, K Labotka, R Dimopoulos, MA Rajkumar, SV CANCER SCIENCE INSTITUTE OF SINGAPORE Humans Multiple Myeloma Lenalidomide Dexamethasone Boron Compounds Chromosome Aberrations Antineoplastic Combined Chemotherapy Protocols 10.1038/s41408-022-00768-5 Blood Cancer Journal 13 1 14- 2023-02-27T00:48:11Z 2023-02-27T00:48:11Z 2023-12-01 2023-02-25T11:40:46Z Article Chng, WJ, Lonial, S, Morgan, GJ, Iida, S, Moreau, P, Kumar, SK, Twumasi-Ankrah, P, Villarreal, M, Dash, AB, Vorog, A, Zhang, X, Suryanarayan, K, Labotka, R, Dimopoulos, MA, Rajkumar, SV (2023-12-01). A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood Cancer Journal 13 (1) : 14-. ScholarBank@NUS Repository. https://doi.org/10.1038/s41408-022-00768-5 2044-5385 https://scholarbank.nus.edu.sg/handle/10635/237477 Springer Science and Business Media LLC Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Humans Multiple Myeloma Lenalidomide Dexamethasone Boron Compounds Chromosome Aberrations Antineoplastic Combined Chemotherapy Protocols
spellingShingle	Humans Multiple Myeloma Lenalidomide Dexamethasone Boron Compounds Chromosome Aberrations Antineoplastic Combined Chemotherapy Protocols Chng, WJ Lonial, S Morgan, GJ Iida, S Moreau, P Kumar, SK Twumasi-Ankrah, P Villarreal, M Dash, AB Vorog, A Zhang, X Suryanarayan, K Labotka, R Dimopoulos, MA Rajkumar, SV A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
description	10.1038/s41408-022-00768-5
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Chng, WJ Lonial, S Morgan, GJ Iida, S Moreau, P Kumar, SK Twumasi-Ankrah, P Villarreal, M Dash, AB Vorog, A Zhang, X Suryanarayan, K Labotka, R Dimopoulos, MA Rajkumar, SV
format	Article
author	Chng, WJ Lonial, S Morgan, GJ Iida, S Moreau, P Kumar, SK Twumasi-Ankrah, P Villarreal, M Dash, AB Vorog, A Zhang, X Suryanarayan, K Labotka, R Dimopoulos, MA Rajkumar, SV
author_sort	Chng, WJ
title	A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
title_short	A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
title_full	A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
title_fullStr	A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
title_full_unstemmed	A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
title_sort	pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
publisher	Springer Science and Business Media LLC
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/237477
_version_	1779155567707684864

A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma

Similar Items